Columbia University Vagelos College of Physicians and Surgeons is the graduate medical school of Columbia University, located at the Columbia University Irving Medical Center in the Washington Heights neighborhood of Manhattan.

During the past decade, Columbia P&S CRS conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 20 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia P&S CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials as a collaborator, "HIV Vaccine Trials Network" with 6 trials as a collaborator, "AIDS Clinical Trials Group" with 4 trials as a collaborator, "Dynavax Technologies Corporation" with 2 trials as a collaborator and "HIV Prevention Trials Network" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Columbia P&S CRS" are "HIV Infections" (37 trials), "HIV-1 Infection" (7 trials), "HIV Infection" (4 trials), "Hepatitis C" (4 trials) and "HIV-1-infection" (3 trials). Many other conditions were trialed in "Columbia P&S CRS" in a lesser frequency.

Most popular intervention types in "Columbia P&S CRS" are "Biological" (29 trials), "Drug" (23 trials), "Other" (5 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "VRC07-523LS" (5 trials), "Ribavirin (RBV)" (3 trials), "10-1074" (2 trials) and "Darunavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Columbia P&S CRS" are 49 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Columbia P&S CRS". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Columbia P&S CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Columbia P&S CRS, 22 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".